Medicine & Health

WashU Medicine researchers have found in mice that two types of immune cells are involved in triggering strong cancer-killing T-cell responses with mRNA vaccines, offering new insights into designing cancer vaccines.

A study by WashU Medicine researchers offers new insight into how environmental factors protect against opioid addiction and support recovery.

A clinical trial co-led by WashU Medicine researchers has shown that a painful complication of blood clots can be treated by inserting a stent into the affected vein.

Researchers from the WashU McKelvey School of Engineering are reshaping our understanding of disease origins and revealing how biomolecular condensates can tip cells from normal behavior to dysfunction.

New data challenge assumptions, showing Missouri Medicaid recipients are largely employed — often in jobs without benefits, reflecting gaps in wages, coverage and rural access.

WashU will launch a doctoral program in neuroengineering in fall 2027, one of only a few in the United States.

New research from Washington University in St. Louis shows that a mother helps to set the biological clock for her babies while they are still in the womb.

Milan G. Chheda, MD, at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation.

Nearly 70% of Missouri schools tested showed traces of potent synthetic opioids, as a new iHeard poll finds most St. Louis residents are unaware of the threat.

WashU Medicine researchers have developed a software, De-ID, that flags sensitive information in data collected through focus groups, surveys and interviews. It allows for easy removal of such details to enable safe sharing.